Zhang H et al. found that the highly expressed SNHG17 modified by METTL3 aggravated the malignant phenotypes in Lung adenocarcinoma (LUAD) gefitinib resistance cells [28]. The gene discussed is METTL3; the disease is lung adenocarcinoma.